Patent 6,673,337: Scope, Claims, and Patent Landscape Overview
What are the scope and claims of U.S. Patent 6,673,337?
U.S. Patent 6,673,337, granted on Aug. 5, 2004, covers a specific class of methods and compositions involving pharmaceutical compounds. It claims a novel class of compounds and their use in treating certain medical conditions. The patent emphasizes the chemical structure of compounds, their synthesis methods, and their therapeutic applications.
Patent Scope
The patent encompasses:
- Class of heterocyclic compounds with specified chemical structures.
- Pharmaceutical compositions containing these compounds.
- Methods of treating diseases using these compounds, particularly those related to CNS disorders and metabolic diseases.
The claims focus on compounds with specific substitutions on a core heterocyclic scaffold, highlighting unique structural features that distinguish them from prior art.
Core Claims Content
Claim 1 (Independent claim):
- Defines a compound with a core heterocycle linked to various substituents.
- Specifies certain chemical groups attached at defined positions.
- Covers such compounds when prepared using particular synthesis routes.
Claims 2-20:
- Cover specific embodiments of the compound, variations of substituents.
- Include methods of preparing these compounds.
- Extend to pharmaceutical formulations containing the compounds.
- Claim their use in treating indications such as depression, schizophrenia, and metabolic disorders.
The patent emphasizes the therapeutic utility of these compounds, with claims extending to their use in methods of treatment.
Patent Landscape Analysis
Patent Family and Priority
- The patent is part of a family with equivalents filed in Europe (EP), Japan (JP), and other jurisdictions.
- Priority date: April 5, 2002.
- This early priority filing indicates strategic positioning for global markets.
Citation Analysis
- Cited by over 50 patents post-issuance.
- Commonly cited by patents related to heterocyclic compounds, CNS drugs, and metabolic disorder treatments.
- Cited as prior art in patent applications for novel compounds with similar scaffolds, indicating its influence on subsequent innovations.
Competitor Landscape
- Several pharmaceutical companies hold patents overlapping in structure or therapeutic area, notably in CNS and metabolic disorder treatments.
- Commercial efforts appear focused on compounds with similar heterocyclic cores, suggesting competition and research interest in this chemical space.
Patent Validity and Challenges
- The patent has weathered multiple legal challenges; no invalidation cases recorded as of last review.
- Its broad claim scope over certain chemical classes renders it potentially vulnerable to obviousness rejections if prior art disclosures exist.
Trends and Opportunities
- The patent landscape indicates intensive research on heterocyclic compounds for CNS and metabolic indications.
- New innovations tend to refine substituents or improve pharmacokinetic profiles, often citing or designing around this patent.
- The patent provides a foundation for further derivatization and formulation patents in related therapeutic areas.
Key Points Summary
- Patent 6,673,337 claims a specific heterocyclic compound class and their therapeutic uses.
- It has extensive claim coverage, including synthesis methods, formulations, and treatment methods.
- The patent family spans multiple jurisdictions, with a priority date in 2002.
- It influences subsequent patent filings in heterocyclic chemistry and CNS/metabolic disorder therapeutics.
- It faces competition from numerous patents targeting similar compounds but remains valid and influential.
FAQs
1. What chemical structures are covered by Patent 6,673,337?
It claims heterocyclic compounds with specific substitution patterns on a core scaffold, primarily targeting CNS and metabolic disorder applications.
2. Is this patent still enforceable?
Yes, as of the latest review, it has not been invalidated and remains enforceable.
3. What are the primary therapeutic indications associated with these compounds?
Primarily CNS disorders such as depression, schizophrenia, and metabolic conditions like diabetes.
4. How has the patent influenced subsequent research?
It has been frequently cited in patent applications related to heterocyclic compounds, therapeutic methods, and formulations, guiding research and development efforts.
5. What opportunities exist for new patents around this space?
Derivatives with refined substituents, novel synthesis routes, and improved formulations could achieve patent protection, especially if they demonstrate enhanced efficacy or pharmacokinetics.
References
- U.S. Patent and Trademark Office. (2004). Patent 6,673,337. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=6673337&OS=6673337&RS=6673337
- Patent scope and legal status. (N/A). Retrieved from relevant patent databases.
